08:56 23-10-2014
MAIN Russian
About us On-line subscription
KazakhstanTajikistanUzbekistanKyrgyzstanTurkmenistanWorld
POLITICSBUSINESSINCIDENTSSOCIETYCULTURESPORTANALYSISSCIENCE
Drug to crack resistant TB

Bishkek (AKIpress) - doctor-x-ray Florian von Groote-Bidlingmaier, medical director of TASK Applied Science, a research unit collaborating with Stellenbosch University, told doctors yesterday about trials of new drugs that might offer a lifeline to patients with drug-resistant TB, Times Live reported.

He was speaking at the World TB Day Symposium, convened by the National Institute for Communicable Diseases, in Johannesburg.

Half-a-million South Africans contract TB every year and one in 25 is likely to develop a form of the disease resistant to treatment. Drug-resistant TB kills at least one in five of the people who contract it.

Most TB drugs have been in use for at least 50 years, Von Groote-Bidlingmaier said, but the development of a new medicine took many years and could cost as much as 10 billion rand ($920.3 million).

It can be years before patients gain access to a new medicine. For example, the drug bedaquiline was developed in 2005 but almost 10 years later it is available to only 200 patients in South Africa in a monitored program with strict eligibility criteria.

Von Groote-Bidlingmaier said that delamanid, conditionally approved by the European Medicines Agency recently, was being tested at three sites in South Africa and abroad. The current trials, if successful, are the last step before the drug is registered.

“TB is not treated with a single drug. There is a need for further trials to test new drugs in combination to see if we can find a better treatment regimen.”

South Africa is the world leader in the exploitation of the GeneXpert machine to detect TB much more quickly. But a study has shown that, though detection has improved, patients are no more likely to start and see their treatment through to completion.

TASK Applied Science performs clinical trials in tuberculosis (TB) in Cape Town, South Africa. TASK can provide assistance to efficiently conduct studies for diagnosis, treatment or prevention of tuberculosis.


Twitterfacebookprint
13:01 25.03.2014
LATEST NEWS
17:52 Astana joins top-21 smart cities in the world - Nazarbayev17:42 225 youth resource centers to launch by end of 2014 in Kazakhstan17:40 Emergency power cut offs inevitable in case of electric network overload, bad weather conditions, says Energy Ministry17:38 Interior Ministers of Tajikistan, Russia consider cooperation in fight against organized crime17:22 Official unemployment rate in Kyrgyzstan makes 2.3% as of October 117:20 Kyrgyz Parliament ratifies agreement with IDA on construction of 56 km of road sections in Batken region for around $37 million17:16 Bishkek holds flashmob dedicated to Snow Leopard Day17:14 Trade between Tajikistan, Moscow region approximately equal to $250 million – Governor of Moscow region17:06 Two snow leopards of Kyrgyzstan are in Almaty Zoo, their sense of vision recovered by 30% – NABU16:57 Man with 25 kg of drugs detained in Chui region16:53 Kyrgyzpatent receives 2,753 applications for intellectual property YTD16:51 Nurlan Nigmatulin appointed as interim Secretary of State of Kazakhstan16:50 Russia's economic blockade by U.S., EU behind growth of US dollar exchange rate against som – expert16:47 Tajikistan, Moscow region plan to sign cooperation agreement in December16:47 OSCE Centre in Astana supports human rights education for police16:40 Farm family from Kyrgyzstan manages to rehabilitate two troubled teens from Germany16:36 Volume of counterfeit goods in Kyrgyzstan reportedly reaches $4.2 bln16:26 Uzbekistan to switchover to closed heating system by 201616:16 Governor of Naryn region, Representative of Aga Khan Development Network discuss construction of University of Central Asia15:59 EU-Central Asia high-level dialogue on security scheduled to be held in Dushanbe
Astana
+8° C
Ashgabat
+22° C
Bishkek
+18° C
Dushanbe
+19° C
Tashkent
+17° C
exchange rates
 
71.29
55.64
9.04
1.36
229.75
180.99
29.59
4.42
6.33
4.99
0.78
0.12
3084.28
2367.40
385.74
61.13
3.62
2.85
0.47
0.07

© AKIpress News Agency - 2001-2014
Use of the AKIpress.com materials must be accompanied by a hyperlink to www.akipress.com
Our address:
Moskovskaya str. 189, Bishkek, the Kyrgyz Republic
e-mail: english@akipress.org, akipressenglish@gmail.com;
Tel/Fax: +996(312)90-07-75